121 related articles for article (PubMed ID: 15170284)
1. Influence of antiplatelet substances on platelet-rich plasma.
Yazawa M; Ogata H; Nakajima T; Watanabe N
J Oral Maxillofac Surg; 2004 Jun; 62(6):714-8. PubMed ID: 15170284
[TBL] [Abstract][Full Text] [Related]
2. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro.
Okuda K; Kawase T; Momose M; Murata M; Saito Y; Suzuki H; Wolff LF; Yoshie H
J Periodontol; 2003 Jun; 74(6):849-57. PubMed ID: 12886996
[TBL] [Abstract][Full Text] [Related]
3. Comparison of point-of-care methods for preparation of platelet concentrate (platelet-rich plasma).
Weibrich G; Kleis WK; Streckbein P; Moergel M; Hitzler WE; Hafner G
Int J Oral Maxillofac Implants; 2012; 27(4):762-9. PubMed ID: 22848876
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report.
Weibrich G; Kleis WK; Hitzler WE; Hafner G
Int J Oral Maxillofac Implants; 2005; 20(1):118-23. PubMed ID: 15747683
[TBL] [Abstract][Full Text] [Related]
5. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system.
Weibrich G; Kleis WK; Hafner G
Int J Oral Maxillofac Implants; 2002; 17(2):184-90. PubMed ID: 11958400
[TBL] [Abstract][Full Text] [Related]
6. The Harvest Smart PRePTM system versus the Friadent-Schütze platelet-rich plasma kit.
Weibrich G; Kleis WK; Buch R; Hitzler WE; Hafner G
Clin Oral Implants Res; 2003 Apr; 14(2):233-9. PubMed ID: 12656885
[TBL] [Abstract][Full Text] [Related]
7. Basic studies on the clinical applications of platelet-rich plasma.
Yazawa M; Ogata H; Nakajima T; Mori T; Watanabe N; Handa M
Cell Transplant; 2003; 12(5):509-18. PubMed ID: 12953925
[TBL] [Abstract][Full Text] [Related]
8. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release.
Everts PA; Brown Mahoney C; Hoffmann JJ; Schönberger JP; Box HA; van Zundert A; Knape JT
Growth Factors; 2006 Sep; 24(3):165-71. PubMed ID: 17079200
[TBL] [Abstract][Full Text] [Related]
9. Influence of calcium salts and bovine thrombin on growth factor release from equine platelet-rich gel supernatants.
Giraldo CE; Álvarez ME; Carmona JU
Vet Comp Orthop Traumatol; 2017 Jan; 30(1):1-7. PubMed ID: 27849108
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid.
Vissinger H; Husted SE; Kristensen SD; Nielsen HK
Angiology; 1993 Aug; 44(8):633-8. PubMed ID: 8342880
[TBL] [Abstract][Full Text] [Related]
11. Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel.
Giraldo CE; Álvarez ME; Carmona JU
BMC Vet Res; 2015 Mar; 11():60. PubMed ID: 25889052
[TBL] [Abstract][Full Text] [Related]
12. [Experimental research on the effects of different activators on the formation of platelet-rich gel and the release of bioactive substances in human platelet-rich plasma].
Yang Y; Zhang W; Cheng B
Zhonghua Shao Shang Za Zhi; 2017 Jan; 33(1):12-17. PubMed ID: 28103989
[No Abstract] [Full Text] [Related]
13. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells.
van den Dolder J; Mooren R; Vloon AP; Stoelinga PJ; Jansen JA
Tissue Eng; 2006 Nov; 12(11):3067-73. PubMed ID: 17518622
[TBL] [Abstract][Full Text] [Related]
14. Counting of platelet derived growth factor and transforming growth factor-beta in platelet-rich-plasma used in jaw bone regeneration.
Tonelli P; Mannelli D; Brancato L; Cinotti S; Morfini M
Minerva Stomatol; 2005; 54(1-2):23-34. PubMed ID: 15902060
[TBL] [Abstract][Full Text] [Related]
15. [The effects of different activators on the release curve of human platelet-rich plasma].
Zhuang YW; Zeng YM; Chen YF; Zhang HP; Chen XY; Yang DY; Wu WJ
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Nov; 41(11):868-872. PubMed ID: 30423630
[No Abstract] [Full Text] [Related]
16. Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations.
Kobayashi Y; Saita Y; Nishio H; Ikeda H; Takazawa Y; Nagao M; Takaku T; Komatsu N; Kaneko K
J Orthop Sci; 2016 Sep; 21(5):683-9. PubMed ID: 27503185
[TBL] [Abstract][Full Text] [Related]
17. The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells.
Ogino Y; Ayukawa Y; Kukita T; Koyano K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):724-9. PubMed ID: 16731390
[TBL] [Abstract][Full Text] [Related]
18. Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen.
Araki J; Jona M; Eto H; Aoi N; Kato H; Suga H; Doi K; Yatomi Y; Yoshimura K
Tissue Eng Part C Methods; 2012 Mar; 18(3):176-85. PubMed ID: 21951067
[TBL] [Abstract][Full Text] [Related]
19. In vitro evidence that the biological effects of platelet-rich plasma on periodontal ligament cells is not mediated solely by constituent transforming-growth factor-beta or platelet-derived growth factor.
Kawase T; Okuda K; Saito Y; Yoshie H
J Periodontol; 2005 May; 76(5):760-7. PubMed ID: 15898937
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Cellular Composition and Cytokine-Release Kinetics of Various Platelet-Rich Plasma Preparations.
Oh JH; Kim W; Park KU; Roh YH
Am J Sports Med; 2015 Dec; 43(12):3062-70. PubMed ID: 26473014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
